Not a U.S. government website. NDD is an independent vulnerability database by Volerion and is not affiliated with or endorsed by NIST or NVD.
CVE-2022-42136 Details
Description
Authenticated mail users, under specific circumstances, could add files with unsanitized content in public folders where the IIS user had permission to access. That action, could lead an attacker to store arbitrary code on that files and execute RCE commands.
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Apr 7, 2025Exploitation: NoneAutomatable: NoTechnical Impact: Total
References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://pastebin.com/ahLNMf5n | CVE | Third Party Advisory |
| https://www.mailenable.com/kb/content/article.asp?ID=ME020737 | CVE | Vendor Advisory |
| https://pastebin.com/ahLNMf5n | [email protected] | Third Party Advisory |
| https://www.mailenable.com/kb/content/article.asp?ID=ME020737 | [email protected] | Vendor Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | [email protected] |
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | CISA-ADP |
Affected Products
| Product | Versions |
|---|---|
| mailenable mailenable | < 8.66 >= 9.0, < 9.85 >= 10.00, < 10.42 |
CPE
Remediation
| |
Change History
6 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Apr 7, 2025 | CVE Modified | CISA-ADP |
| Nov 21, 2024 | CVE Modified | CVE |
| May 14, 2024 | CVE Modified | [email protected] |
| Jan 23, 2023 | Initial Analysis | [email protected] |